4.6 Article

The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants

Journal

AMERICAN JOURNAL OF TRANSPLANTATION
Volume 8, Issue 2, Pages 277-287

Publisher

BLACKWELL PUBLISHING
DOI: 10.1111/j.1600-6143.2007.02062.x

Keywords

accelerated rejection; allograft vasculopathy; angiogenesis; arrays; cardiac allograft rejection; cardiac allograft vasculopathy; chronic allograft rejection; cyclosporine A; cytomegalovirus (CMV); cytomegalovirus infection; transplant vascular sclerosis; virus

Funding

  1. NCRR NIH HHS [P51 RR000163-496162, P51 RR000163, P51 RR000163-486828] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL085451, HL083194, HL66238-01] Funding Source: Medline
  3. NIAID NIH HHS [R01 AI070890, R01 AI070890-01A2] Funding Source: Medline

Ask authors/readers for more resources

Human cytomegalovirus (HCMV) accelerates transplant vascular sclerosis (TVS), a consequence of angiogenesis (AG) and wound repair (WR). While HCMV can be localized to TVS lesions, the low number of infected cells suggests a global effect on target tissues. We used microarray analysis followed by real-time-polymerase chain reaction (RT-PCR) in an RCMV-accelerated TVS rat cardiac transplant model to determine whether CMV activates host WR and AG factors. Dysregulated cellular genes in allografts from RCMV-infected recipients were compared to those from uninfected recipients and native hearts. We demonstrated that RCMV upregulates the genes involved in WR and AG, which was highest during the critical time of TVS acceleration (21-28 days). Using a standard in vitro AG assay, virus and serum-free supernatants collected at 48 h postinfection significantly induced endothelial cell (EC) migration, branching and tubule formation compared to supernatants from mock-infected cells. Supernatants from ultraviolet (UV)-inactivated RCMV-infected cells failed to induce AG, indicating that virus replication is required. Upregulation of WR and AG genes occurs during the critical period of CMV-accelerated TVS. Targeting these genes may prevent this process and improve allograft survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available